Abstract:OBJECTIVE:To evaluate the correlation of CD44v6 and sCD44v6 expression with the biological activity of gastric carcinoma. METHODS:Mucosa samples from 103 gastric carcinoma patients and 10 healthy persons (control) were examined using immunohistochemical SP method; sCD44v6 level in peripheral blood samples was detected with ELISA in 86 gastric cancer patients, 30 gastric ulcer patients and 30 healthy controls. The follow-up period was 3-91 months for 88 patients in CD44v6 group and 1-91 months for 55 patients in sCD44v6 group. RESULTS:(1) Positive expression of CD44v6 was found in 60.2% of gastric carcinoma, where as 0% in the normal gastric mucosa. CD44v6 protein expression was positively correlated with TNM stage, perigastric lymph node metastasis, presence of cancerous embolic angiopathy and Borrmann classification (P <0.05), but was not correlated with invasion depth, differentiation, metastasis and survival (P > 0.05); 77.8% of the patient with liver metastasis had a strong CD44v6 protein expression. (2) sCD44v6 level in the peripheral blood of gastric carcinoma patient was significantly higher than that in gastric ulcer patient or healthy control; Compared with palliative gastrectomy, sCD44v6 level significantly went down after radical operation. No relationship between sCD44v6 level and the pathological features was found, which included invasion depth, perigastric lymph node metastasis, presence of cancerous embolic angiopathy, differentiation and Borrmann classification; The survival in the high sCD44v6 level group was longer than that in low sCD44v6 level group ( P = 0.0281), but no significant difference was observed by Cox Regression analysis (P = 0.415). (3) No apparent correlation was observed between CD44v6 expression in gastric cancer and sCD44v6 concentration in peripheral blood (P>0.05). CONCLUSION:Detection of CD44v6 expression in the gastric cancer may be helpful in evaluating the biological features and the survival in gastric carcinoma. The level of sCD44v6 in the blood may be also helpful in differential diagnosis, evaluation of surgical treatment and biological activity for gastric cancer. No apparent correlation is observed between CD44v6 expression in the cancer and that of sCD44v6 in the blood.

The Clinical Signiifcance of Investigating the Serum Concentrations of Scd40, Scd40l and Plasma Concentrations of CD62P in Patients with Lung Cancer

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

[Quantitative Studies on Expression of Peripheral Blood CD44 and CD54 in Non-Small Cell Lung Carcinoma].

Clinical Significance of the Serum-Soluble Intercellular Adhesion Molecule-1 in Patients Undergoing Radical Resection of Lung Cancer

Activated Changes of Platelet Ultra Microstructure and Plasma Granule Membrane Protein 140 in Patients with Non-Small Cell Lung Cancer.

Expression and clinical significance of sCD40 in patients with B-cell malignancies

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

Serum sCD44s and sCD44v6 levels in breast cancer patients

[Serum Levels of Endostatin and VEGF in Non-Small Cell Lung Cancer Patients and the Relationship with the Clinical Pathophysiological Characteristics].

Serum levels of Sicam-1 and TNF-α and their significance in patients with lung cancer in late stage

Study on significance of serum levels of intercellular adhesion molecule-1 in patients with lung cancer

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Clinical Significance of Serum Scd40l Changes in Patients with Different Types of Coronary Heart Diseases

The prognostic value of plasma soluble CD40 ligand levels in patients with nasopharyngeal carcinoma

Detection of D2-40-positive lymphatic microvessel density and its clinical significance in lung cancer

Functional Significance of CD40 and CD40 Ligand Linking on Human Lung Cells

Clinical Signification on CD44 Express of Peripheral Blood Cells in Pat ients with Primary Hepatic Carcinoma

Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis

Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients

Alterations of Serum Inflammatory Biomarkers in the Healthy and Lung Cancer Patients Before and Post Chemotherapy

The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation